Cardiovascular	cardiovascular	O	O	OTHERS	I
complications	complications	O	O	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
for	for	O	O	O	O
preterm	preterm	O	O	OTHERS	I
labor	labor	O	O	OTHERS	I
.	.	O	O	O	O

Severe	severe	O	O	O	O
cardiovascular	cardiovascular	O	O	OTHERS	I
complications	complications	O	O	OTHERS	I
occurred	occurred	O	O	O	O
in	in	O	O	O	O
eight	eight	O	O	O	O
of	of	O	O	O	O
160	160	O	O	O	O
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
terbutaline	terbutaline	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
preterm	preterm	O	O	OTHERS	I
labor	labor	O	O	OTHERS	I
.	.	O	O	O	O

Associated	associated	O	O	O	O
corticosteroid	corticosteroid	O	O	OTHERS	I
therapy	therapy	O	O	O	O
and	and	O	O	O	O
twin	twin	O	O	O	O
gestations	gestations	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
predisposing	predisposing	O	O	O	O
factors	factors	O	O	O	O
.	.	O	O	O	O

Potential	potential	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
pathophysiology	pathophysiology	O	O	O	O
are	are	O	O	O	O
briefly	briefly	O	O	O	O
discussed	discussed	O	O	O	O
.	.	O	O	O	O

